128 related articles for article (PubMed ID: 17460536)
1. Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.
Adams GL; Shaw LK; Tuttle RH; Hanson MW; Pagnanelli R; Borges-Neto S
Nucl Med Commun; 2007 Jun; 28(6):457-63. PubMed ID: 17460536
[TBL] [Abstract][Full Text] [Related]
2. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
3. Incremental prognostic value of (99m)Tc-tetrofosmin myocardial SPECT after percutaneous coronary intervention.
Georgoulias P; Tzavara C; Demakopoulos N; Giannakou S; Valotassiou V; Tsougos I; Xaplanteris P; Fezoulidis I
Ann Nucl Med; 2008 Dec; 22(10):899-909. PubMed ID: 19142709
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention.
Georgoulias P; Demakopoulos N; Tzavara C; Giannakou S; Valotassiou V; Tsougos I; Xaplanteris P; Fezoulidis I
Clin Nucl Med; 2008 Nov; 33(11):743-7. PubMed ID: 18936603
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Vourvouri EC; Bountioukos M; Rizzello V; Agricola E; Valkema R; Roelandt JR; Poldermans D
Am J Cardiol; 2003 Feb; 91(4):408-11. PubMed ID: 12586253
[TBL] [Abstract][Full Text] [Related]
8. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing.
Schinkel AF; Elhendy A; Biagini E; van Domburg RT; Valkema R; Rizello V; Pedone C; Simoons M; Bax JJ; Poldermans D
J Nucl Med; 2005 Jan; 46(1):12-8. PubMed ID: 15632027
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.
Boiten HJ; van der Sijde JN; Ruitinga PR; Valkema R; Geleijnse ML; Sijbrands EJ; van Domburg RT; Schinkel AF
J Nucl Cardiol; 2012 Oct; 19(5):907-13. PubMed ID: 22875719
[TBL] [Abstract][Full Text] [Related]
10. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
[TBL] [Abstract][Full Text] [Related]
11. Prediction of 14-year cardiovascular outcomes by dobutamine stress
Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
[TBL] [Abstract][Full Text] [Related]
12. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.
Soman P; Taillefer R; DePuey EG; Udelson JE; Lahiri A
J Am Coll Cardiol; 2001 Feb; 37(2):458-62. PubMed ID: 11216963
[TBL] [Abstract][Full Text] [Related]
13. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S
Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging.
Leslie WD; Tully SA; Yogendran MS; Ward LM; Nour KA; Metge CJ
J Nucl Med; 2005 Feb; 46(2):204-11. PubMed ID: 15695777
[TBL] [Abstract][Full Text] [Related]
15. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
16. Combined supine and prone myocardial perfusion single-photon emission computed tomography with a cadmium zinc telluride camera for detection of coronary artery disease.
Nishiyama Y; Miyagawa M; Kawaguchi N; Nakamura M; Kido T; Kurata A; Kido T; Ogimoto A; Higaki J; Mochizuki T
Circ J; 2014; 78(5):1169-75. PubMed ID: 24572492
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up.
Schinkel AF; Elhendy A; Van Domburg RT; Bax JJ; Valkema R; Roelandt JR; Poldermans D
Radiology; 2002 Dec; 225(3):701-6. PubMed ID: 12461248
[TBL] [Abstract][Full Text] [Related]
18. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
Gremillet E; Champailler A
Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
[TBL] [Abstract][Full Text] [Related]
19. The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography.
Peace RA; Lloyd JJ
Nucl Med Commun; 2005 Jan; 26(1):17-24. PubMed ID: 15604943
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
Widding A; Hesse B; Gadsboll N
Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
